Search results
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation -...
EconoTimes· 6 days agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU...
'Seems Low:' Elon Musk Questions Pfizer's $0 Tax Bill, But Did Tesla Pony Up To Uncle Sam? - Pfizer...
Benzinga· 2 days agoClair, a contributor to satirical outlet The Babylon Bee, shared a blog post. The post alleged the...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 4 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
AstraZeneca withdraws its COVID-19 vaccine from global market
The Hill· 7 days agoThe shot, which was never authorized in the U.S., was widely used across the world in the early part...
AstraZeneca Is Withdrawing Its Covid Vaccine Worldwide, Citing Low Demand
New York Times· 7 days agoThe shot is no longer being manufactured or supplied, and it is no longer authorized for use in...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 2 days agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022....
A 'Decline in Demand' Leads to the End for This COVID Vaccine
newser· 7 days agoMore than 3 billion doses of the vaccine were administered in other countries around the world...
AstraZeneca pulls COVID-19 vaccine from global markets
United Press International via Yahoo News· 7 days agoBritish-Swedish drug maker AstaZeneca is pulling its Vaxzevria COVID-19 vaccine from sale globally....
AstraZeneca's COVID vaccine withdrawn—it was a victim of misinformation right to the end, researcher...
Medical Xpress· 6 days agoThis development has been covered in various media outlets as primarily related to the known...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 5 days ago, opens new tab respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and...